Summary
- Current Price
- As of today, NTLA price is $11.94, up +6.23% on
- Current Price All-Time High
- NTLA price is currently -94.11% below its historical high of $202.73 set on
- Market Cap
- NTLA current market cap is $2B, up +38.21% over the past 365 days
- Revenue
- NTLA current annual revenue is $67.67M, up +16.92% year-over-year
- Next Earnings
- The next earnings release for NTLA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Intellia Therapeutics, Inc. |
| Ticker | NASDAQ: NTLA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | intelliatx.com |
| Employees | 403 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $11.94 | |
| Price, 1D Change | +6.23% | |
| $2B | ||
| - | ||
| - | ||
| 2.27 | ||
| $67.67M | ||
| Revenue, 1Y Change | +16.92% | |
| -$3.81 | ||
| EPS, 1Y Change | +27.47% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.81 | ||
| EPS Estimate | -$3.03 | N/A |
| EPS Est. Change | +20.38% | N/A |
| $67.67M | ||
| Revenue Estimate | $60.86M | N/A |
| Revenue Est. Change | -10.07% | N/A |
| Current Price | $11.94 | |
| Price Target | $16.00 | - |
| Price Tgt. Change | +34.00% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.27 | -$5.25 | +0.43% | |
| -$4.00 | -$3.81 | +4.80% | |
| -$3.03 | N/A | +20.38% | |
| -$1.73 | N/A | +54.54% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $52.11M | $57.88M | +11.08% | |
| $57.09M | $67.67M | +18.53% | |
| $60.86M | N/A | -10.07% | |
| $339.51M | N/A | +401.71% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $11.94 | |
| $12.72 | ||
| $13.54 | ||
| $13.17 | ||
| $12.87 | ||
| -$0.78 | ||
| 2.27 | ||
| $0.79 | ||
| 47.57 | ||
| 51.53% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $67.67M | ||
| -$3.81 | ||
| $0.00 | ||
| 0.00% | ||
| -$440.99M | ||
| -651.67% | ||
| -$412.69M | ||
| -609.85% | ||
| -$425.07M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.00 | ||
| 5.08 | ||
| 5.08 | ||
| - | ||
| 4 | ||
| 0.51 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 28.04 | ||
| 2.29 | ||
| -3.19 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $671.39M | ||
| $605.13M | ||
| $842.13M | ||
| $527.71M | ||
| $170.73M | ||
| $103.88M | ||
| $93.33M | ||
| $26.48M | ||
| $20.25M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $480.37M | ||
| $440.99M | ||
| $15.92M | ||
| $119.80M | ||
| $15.92M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$394.74M | ||
| $228.03M | ||
| $131.49M | ||
| $1.13M | ||
| -$395.87M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Evercore ISI Group | → | |
| Wolfe Research | → | |
| Wedbush | → | |
| Canaccord Genuity | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Citizens | → | |
| HC Wainwright & Co. | → | |
| Bernstein | → | |
| Wedbush | → |
Analyst sentiment
Institutional ownership
No data
Screeners with NTLA
FAQ
- What is the ticker symbol for Intellia Therapeutics, Inc.?
- The ticker symbol for Intellia Therapeutics, Inc. is NASDAQ:NTLA
- Does Intellia Therapeutics, Inc. pay dividends?
- No, Intellia Therapeutics, Inc. does not pay dividends
- What sector is Intellia Therapeutics, Inc. in?
- Intellia Therapeutics, Inc. is in the Healthcare sector
- What industry is Intellia Therapeutics, Inc. in?
- Intellia Therapeutics, Inc. is in the Biotechnology industry
- What country is Intellia Therapeutics, Inc. based in?
- Intellia Therapeutics, Inc. is headquartered in United States
- When did Intellia Therapeutics, Inc. go public?
- Intellia Therapeutics, Inc. initial public offering (IPO) was on May 6, 2016
- Is Intellia Therapeutics, Inc. in the S&P 500?
- No, Intellia Therapeutics, Inc. is not included in the S&P 500 index
- Is Intellia Therapeutics, Inc. in the NASDAQ 100?
- No, Intellia Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Intellia Therapeutics, Inc. in the Dow Jones?
- No, Intellia Therapeutics, Inc. is not included in the Dow Jones index
- When was Intellia Therapeutics, Inc. last earnings report?
- Intellia Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Intellia Therapeutics, Inc. report earnings?
- The next expected earnings date for Intellia Therapeutics, Inc. is November 5, 2026
Data Sources & References
- NTLA Official Website www.intelliatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1652130/000119312526076550/0001193125-26-076550-index.htm
- NTLA Profile on Yahoo Finance finance.yahoo.com/quote/NTLA
- NTLA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ntla